The next board meeting for ProQR Therapeutics N.V is on 21 Oct 2025 for the purpose of ProQR Chardan’s 9th Annual Genetic Medicines Conference 2025See details
ProQR Therapeutics N.V has a share price target of US$ 9, revenue growth forecast of 9.4%, and profit growth estimate of -61.4% for FY25, based on top 8 analyst calls.